Stay updated on SAGE-217 Safety in MDD Insomnia Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 Safety in MDD Insomnia Clinical Trial page.

Latest updates to the SAGE-217 Safety in MDD Insomnia Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe NIH announcement about the terminology transition from “Artificial Intelligence” to “Super Intelligence” no longer appears at the top of the page.SummaryDifference1%

- Check17 days agoChange DetectedThe site revision in the footer changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error rather than study details.SummaryDifference0.2%

- Check24 days agoChange DetectedA sitewide NIH notice appears above the page, announcing a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2. The page still displays a 403 error instead of the study record.SummaryDifference0.2%

- Check38 days agoChange DetectedThe revision identifier in the footer changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check59 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study record details, blocking access to core information and related documents about the trial.SummaryDifference19%

Stay in the know with updates to SAGE-217 Safety in MDD Insomnia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 Safety in MDD Insomnia Clinical Trial page.